Ig H chain V region gene (V gene) rearrangement and expression during B cell ontogeny apparently is an ordered and restricted process. In mice there is a developmental bias toward rearrangement and expression of a relatively small subset of Ig V genes located most proximal to the J locus in the germline DNA (1, 2). Although the relationship between developmental V gene expression and V gene location is less well understood in man, the repertoire of expressed V genes during early B cell ontogeny similarly is restricted, apparently containing only 9-39 genes at 130 d of gestation (3).
detects a K L chain-associated CRI present on over one-third of all human IgM RF paraproteins and many other IgM autoantibodies (9, 10 ) . Yet, an additional mAb specific for a distinct RF H chain-associated CRI, named Lcl (11), labeled neoplastic Ig-expressing B cells from 7 of 56 (13%) patients with CLL or SL NHL (8) . Another two patients (4%) in this study were found to have malignant cells reactive with B6, a third mAb specific for an autoantibody H chain-associated CRI that is distinct from either the G6 CRI or Lcl CRI (8) .
Like the G6 CRI, these CRIs may be serologic markers for expression of conserved Ig V genes . 17 .109-reactive neoplastic cells from unrelated CLL or SL NHL patients express homologous V,, genes that share 99% homology with Humkv325 (12, 13) , a VK III gene isolated from placental DNA (14) . Similarly, preliminary data indicate that Lcl and B6 each react with CRIs encoded by a V gene(s) of the V 4 and V 3 V region subgroups, respectively. As such, these anti-CRI mAbs apparently detect the protein product(s) of conserved Ig V genes that frequently are expressed in CLL and related B cell malignancies .
Because the fetal repertoire apparently shares with CLL the high frequency expression of the VH 1 gene used to encode the G6 CRI, we examined splenic tissue from a 23-wk-old fetus for lymphocytes reactive with G6 and three other mAbs specific for autoantibody-associated CRIs that commonly are detected on the Ig produced in CLL and SL NHL .
Materials and Methods
Tissue Samples. Splenic tissue was obtained from a spontaneously aborted fetus at 161 d of gestation . Blocks of splenic tissue, N1 cm 3 in volume, were frozen in optimal cutting temperature embedding medium (Miles Laboratories, Inc ., Naperville, IL), using methods described previously (15) .
Immunohistochemistry. 4-Am sections were prepared from the tissue blocks of frozen fetal spleen. Enzyme immunohistochemical staining was performed using an avidin-biotin complex immunoperoxidase technique as described (4, 15) . Comparison staining with isotype control murine mAbs was performed at concentrations equal to those used with the specific mAb in each experiment. The percent of stained cells within the primary follicles was determined using photomicrographs ofstained primary follicles . For each mAb or mAb combination, a minimum of 100 cells in each of at least five follicles were examined. Statistical calculations of the mean, SD, and student's t test ofthe percent values were performed on a MacIntosh Ilcx computer (Apple Computer Co., Cupertino, CA) using Statview II software (Brainpower Inc ., Calabasas, CA) .
Antibodies . B6, a murine IgGI mAb generated against the H chain of an IgM RF paraprotein, and G6, a murine IgGI mAb (5), were provided by Drs . Rizgar Mageed and Roy Jefferis (University of Birmington, Birmingham, England) . An IgGl mAb specific for a VK IIIb framework determinant(s) (16) , was obtained from Dr. George Abraham (University of Rochester, Rochester, NY) . mAb 17 .109 is as described (9) . Lcl, an IgG1 mAb (11) , was the gift of Dr. J. G. P Sissons (Cambridge University, Cambridge, England) . Hybridomas obtained from the American Type Culture Collection (Bethesda, MD) were OKT3, an IgG2a anti-CD3, and DA4-4, an IgG1 antihuman k H chain . SC-1, an IgG2a mAb reactive with human CD5, was provided by Dr. Robert Fox (Scripps Clinic and Research Foundation) . Anti-human K or A L chain-producing hybridomas were as described (17) . Antibodies were purified from ascites via ammonium sulfate precipitation and protein A-Sepharose column chromatography (Bio-Rad Laboratories, Richmond, CA) .
Results
Primary B cell follicles can be identified in the human fetal spleen at 23 wk of gestation . These follicles generally appear as nodular collections of small lympho-cytes that uniformly bind mAbs specific for human IgM (data not shown). Such follicles typically are contiguous to perivascular clusters of T lymphocytes that bind mAbs to CD3 (Fig . 1, left) or CD5 (Fig . 1, right) . The anti-CD5 mAb labels a larger proportion of lymphocytes than the anti-CD3 mAb, including lymphocytes within the primary follicles ( Fig. 1, arrows) .
We examined photomicrographs of individual follicles from the stained fetal spleen to determine the proportions of follicular lymphocytes that are labeled with a particular mAb or mAb combination. By dividing the number of stained cells by the number of cells within the follicle, we find that 57 % (f 3 % SD) of the cells within each follicle express tt Lchains (Fig. 2, C) , and 41% (t 2%) of the lymphocytes express X L chains . Simultaneous staining with both anti-u and anti-X mAbs labeled virtually all the cells within each B cell follicle (data not shown) .
High proportions of the lymphocytes within each primary follicle were stained with any one of the anti-CRI mAbs (Table I ) . For any one mAb, there exists little variation between different follicles in the percent number of cells stained. Thus, mAbs specific for antibody H chain-associated CRIB, G6, B6, and Lcl, each stained 6.9% (±1.7% SD), 5 .5% (±I .0% SD), and 17% (±0.6% SD), respectively, of the cells within each B cell follicle identified . mAb 17 .109, specific for a « L chain-associated CRI, stained 6.8% (t0.8%) of the follicular lymphocytes.
Simultaneous incubation of the splenic tissue with two or more mAbs allowed us to distinguish overlapping subsets from noncongruous subsets of mAb-reactive lymphocytes. A mAb specific for VKIIIb framework determinants, for example, stained 9.4% (t1%) of the cells within each follicle (Table I) . That 17 .109-reactive cells comprised a large subset of such VKIII+ lymphocytes was demonstrated in tissue sections that were stained with both antibodies . The percent of the cells reactive to both 17 .109 and the antiVKIIIb mAbs, 9.3% (±0.5), was comparable with the proportion of cells labeled by the anti VKI11b mAb alone. However, cells reactive with G6, B6, or Lcl apparently belong to discrete cell subsets, in that simultaneous staining with any combination of two such anti-CRI mAbs yielded a per-FIGURE 1. Primary lymphocyte follicles in 23-wk-old human fetal spleen (x20) . Contiguous tissue sections were labeled with IgG2a mAbs specific for CD3 (kft) or CD5 (right) . Depicted are the same lymphoid aggregates that were identified in the two sections . The primary 13 cell follicle (arrow) lies to the left of a perivascular nodule of T lymphocytes . cent labeling of follicular cells that was comparable with the sum of the proportions of cells labeled by each mAb separately (Table I) Discussion This study indicates that the antibodies produced during early B cell development are comparable with those expressed in CLL. This was inferred from a recent study demonstrating that G6, a major crossreactive idiotype in CLL (4), is encoded by a V1 gene that was isolated repeatedly from independent clones of a 130-d fetal liver cDNA library (3, 6) . However, this study directly demonstrates that the protein product of this V.1 gene actually is expressed frequently by disparate cells within human fetal lymphoid tissue . In addition, this study extends on previous work by demonstrating that other CRIs that frequently are expressed in CLL are present on primary follicular B cells. In particular, the K L ch expressed by ti7% of all cells, and presumably by 12 within the primary B cell follicles. Leukemic cells beari have been found to express Humkv325, a conserved VK at single copy in the human haploid genome (12, 13) . that VK gene expression by fetal splenocytes is not ran be expressed by >10% of all K L chain-bearing cells within the human fetal spleen. Of note, this is a frequency similar to that noted among leukemic populations from unrelated persons with CLL (7) .
That the antibodies produced during early B cell development are comparable with those expressed in CLL or SL NHL may reflect the cell of origin for these B cell malignancies (reviewed in reference 18). Both neoplasms commonly coexpress B cell surface antigens and the 67-kD pan-T lymphocyte surface antigen CD5 (Leu-1). As such, both may be considered neoplasms of the CD5 B cell . Although only a minor lymphocyte subpopulation in the lymphoid organs and peripheral blood ofnormal adults (18) (19) (20) (21) (22) , CD5 B cells constitute the predominant B cell subpopulation in human fetal liver and spleen, presumably when the repertoire of expressed V genes still is restricted (23, 24) .
This study also indicates that many of the lymphocytes in early human B cell ontogeny express surface Igs that are structurally related to IgM autoantibodies . Although it was originally hypothesized that the restricted expression ofhuman V genes may serve to exclude the appearance ofautoantibodies before the emergence ofeffective T cell immunity (3), studies in the mouse have indicated that many of the antibodies produced in early B cell ontogeny have anti-self reactivity (25) . That the antibodies produced by fetal splenic B cells also may have anti-self reactivity is indicated by our finding that the proportion of cells that react with both the 17 .109 and G6 mAbs is less than the sum of the proportions of cells that label with each antibody alone. This implies that a fraction of the fetal splenocytes may coexpress both CRIB . Human IgM paraproteins that coexpress both CRIB invariably have been noted to have RF activity (26) . Also, the physiologic counterpart to CLL, the CD5 B cell, apparently constitutes a separate B cell lineage that can produce IgM autoantibodies spontaneously in vitro (19, 20, (27) (28) (29) . Moreover, a high proportion of CLL patients have leukemic cells that express sIg with RF activity (17, 30, 31) . Expression of such autoantibodies may be important developmentally, as this may serve to stimulate constitutively early B lymphocytes that have undergone successful Ig V gene rearrangement in the sterile fetal environment.
This study also provides new insight into the physiology of the primary follicle ofthe human fetal spleen . This is the first study to examine individual B cell follicles in-associated 17.109 CRI is of K L chain-bearing cells, g the 17.109 C RI invariably ne that apparently is present Thus, our findings indicate om, in that Humkv325 may for the proportions of cells that express idiotypec determinants that reflect expression of certain highly conserved Ig V region genes. Previous studies demonstrating restriction in the fetal B cell repertoire (3) could not provide any information on whether individual B cell follicles express all or only part of this restricted repertoire . Conceivably, each B cell follicle could originate from a few, if not one, common clonal ancestors in which successful Ig V gene rearrangement had occurred . However, our analyses reveal that each examined follicle had cells that expressed disparate H chain-associated CRIB that presumably are encoded by distinct Ig V genes. Moreover, there is little variation between primary follicles in the proportions of cells that express a particular CRI. Finally, costaining with two or more mAbs specific for such CRIB labeled a proportion of cells comparable with the sum of the percentages of cells labeled by each mAb alone. These data indicate that the repertoire of Ig V gene rearrangements within any given follicle is heterogeneous. Furthermore, as there exists little fluctuation between follicles in the relative proportions of cells that express any one CRI, the repertoire of Ig V genes expressed in any given follicle may be representative of the entire splenic fetal B cell repertoire. As such, the programmed development of the Ig V gene repertoire apparently is regulated at the level of the individual primary B cell follicle.
Summary
At 23 wk of gestation, the fetal spleen contains follicles of lymphocytes that coexpress B cell differentiation antigens, surface Ig, and the 67-kD pan-T lymphocyte antigen, CD5 (Leu-1). Such cells are thought to represent the normal equivalent cells of B chronic lymphocytec leukemia (CLL). This B cell leukemia is distinctive in that high proportions of patients have leukemic cells that express sIg bearing one or more crossreactive idiotypes (CRIB) that commonly are found on IgM autoantibodies . We performed immunohistochemical studies on fetal spleen at 23 wk of gestation using a panel of mAbs specific for autoantibody-associated CRIB . We find that high proportions (5-17%) of the lymphocytes within each follicle react with any one of the anti-CRI mAbs . Furthermore, there is little variation between primary follicles in the proportions of cells that express a particular CRI. Using a cocktail of four anti-CRI mAbs, we detect autoantibody-associated CRIs on approximately onethird of the lymphocytes within each of the primary B cell follicles. These data indicate that the many of the Igs produced during early B cell development may be structurally related to IgM autoantibodies and to Ig expressed in CLL and related CD5 B cell malignancies. Furthermore, these studies suggest that the repertoire of Ig V genes expressed in each primary B cell follicle may be representative of the total restricted Ig V gene repertoire expressed during early B cell ontogeny.
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